1. Immunology/Inflammation Membrane Transporter/Ion Channel
  2. NOD-like Receptor (NLR) URAT1 Interleukin Related OAT GLUT
  3. NLRP3/URAT1-IN-1

NLRP3/URAT1-IN-1 是一种具有口服活性的 NLRP3URAT1 双重抑制剂 (IC50 = 3.81 μM)。NLRP3/URAT1-IN-1 抑制 LPS (HY-D1056) 和 ATP 刺激的小鼠骨髓源性巨噬细胞 (BMDMs) 中 IL-1β 的释放,IC50 值为 2.61 μM。NLRP3/URAT1-IN-1 降低急性高尿酸血症 (HUA) 小鼠的血清尿酸 (SUA) 水平,并缓解肝/肾损伤。NLRP3/URAT1-IN-1 可用于痛风和高尿酸血症的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

NLRP3/URAT1-IN-1

NLRP3/URAT1-IN-1 Chemical Structure

CAS No. : 2994637-53-3

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 NOD-like Receptor (NLR) 亚型特异性产品:

查看 Interleukin Related 亚型特异性产品:

查看 GLUT 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

NLRP3/URAT1-IN-1 is an orally active double inhibitor of NLRP3 and URAT1 (IC50 = 3.81 μM). NLRP3/URAT1-IN-1 inhibits IL-1β release in LPS (HY-D1056) and ATP-stimulated mouse bone marrow-derived macrophages (BMDMs), with an IC50 of 2.61 μM. NLRP3/URAT1-IN-1 reduces serum uric acid (SUA) and alleviates liver/kidney damage in mice with acute hyperuricemia (HUA). NLRP3/URAT1-IN-1can be used for the study of gout and hyperuricemia[1].

IC50 & Target[1]

IL-1β

2.61 μM (IC50)

NLRP3

 

OAT4

6.08 μM (IC50)

URAT1

3.81 μM (IC50)

GLUT9

11.02 μM (IC50)

体外研究
(In Vitro)

NLRP3/URAT1-IN-1 (Compound 32) 在 HEK293-URAT1 过表达细胞中对 URAT1 表现出强效抑制活性,IC50 值为 3.81 μM[1]
NLRP3/URAT1-IN-1 在 HEK293-OAT4 过表达细胞中使用 6-羧基荧光素 (6-CFL) 作为底物时,对 OAT4 显示出抑制作用,IC50 值为 6.08 μM[1]
NLRP3/URAT1-IN-1 通过全细胞膜片钳记录在 HEK293-GLUT9 过表达细胞中对 GLUT9 发挥抑制活性,IC50 值为 11.02 μM[1]
NLRP3/URAT1-IN-1 (3 μM, 45 min) 抑制 LPS (HY-D1056) 和 ATP 刺激的小鼠骨髓源性巨噬细胞 (BMDMs) 中 IL-1β 的释放,IC50 值为 2.61 μM,且不影响 TNF-α 和 IL-6 的产生[1]
NLRP3/URAT1-IN-1 在人肝微粒体中对 CYP2C9 (IC50 = 2.77 μM) 和 CYP2C19 (IC50 = 2.03 μM) 表现出适中的抑制活性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

NLRP3/URAT1-IN-1 (Compound 32) (2 mg/kg,口服,单次剂量) 显著降低由 Hypoxanthine (HY-N0091) 和 Potassium oxonate (HY-17511) 诱导的急性高尿酸血症 (HUA) 小鼠的血清尿酸 (SUA) 水平[1].
NLRP3/URAT1-IN-1 (2 mg/kg,口服,每日给药,3 天) 显著减轻由关节腔内注射 MSU 晶体诱导的急性痛风性关节炎大鼠的踝关节肿胀[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 3-week-old healthy Kunming (KM) mice with acute hyperuricemia (HUA) induced by hypoxanthine and potassium oxonate[1]
Dosage: 2 mg/kg
Administration: p.o., single dose
Result: Reduced serum uric acid (SUA) levels.
Animal Model: 7-8-week-old male Sprague-Dawley (SD) rats (180-220 g) with acute gouty arthritis induced by intra-articular injection of MSU crystals[1]
Dosage: 2 mg/kg
Administration: p.o., daily, 3 days
Result: Reduced ankle swelling and IL-1β release.
分子量

525.44

Formula

C24H17BrN2O3S2

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
NLRP3/URAT1-IN-1
目录号:
HY-175645
需求量: